Glaxo Memo on Avandia Is Questioned
Thursday, August 19, 2010 - 12:42
in Health & Medicine
A federal official and some F.D.A. panel members take issue with the contents of a letter about a drug trial at the heart of controversies over the heart risks of the diabetes drug.
